Tenaya Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Higa Tomohiro | SVP, Finance | Sale | 1,367 | $1.33 | $1,818 | 93,971 | Nov 17, 2025 |
| Tingley Whittemore | Chief Medical Officer | Sale | 2,877 | $1.33 | $3,826 | 169,926 | Nov 17, 2025 |
| Ali Faraz | Chief Executive Officer | Sale | 3,126 | $1.33 | $4,158 | 299,666 | Nov 17, 2025 |
| Higa Tomohiro | SVP, Finance | Sale | 523 | $1.25 | $654 | 97,777 | Aug 18, 2025 |
| Tingley Whittemore | Chief Medical Officer | Sale | 1,837 | $1.25 | $2,296 | 172,803 | Aug 18, 2025 |
| Ali Faraz | Chief Executive Officer | Sale | 4,920 | $1.25 | $6,150 | 302,792 | Aug 18, 2025 |
| Higa Tomohiro | SVP, Finance | Sale | 1,390 | $0.44 | $612 | 98,300 | May 16, 2025 |
| Tingley Whittemore | Chief Medical Officer | Sale | 2,937 | $0.44 | $1,292 | 171,856 | May 16, 2025 |
| Ali Faraz | Chief Executive Officer | Sale | 3,189 | $0.44 | $1,403 | 317,325 | May 16, 2025 |
| Higa Tomohiro | SVP, Finance | Sale | 620 | $0.54 | $335 | 100,535 | Mar 10, 2025 |
| Tingley Whittemore | Chief Medical Officer | Sale | 4,073 | $0.54 | $2,199 | 176,391 | Mar 10, 2025 |
| Ali Faraz | Chief Executive Officer | Sale | 5,794 | $0.54 | $3,129 | 324,461 | Mar 10, 2025 |
| COLUMN GROUP III, LP | — | Purchase | 35,714,284 | $0.70 | $24,999,999 | 49,313,559 | Mar 5, 2025 |
| GOEDDEL DAVID V | — | Purchase | 35,714,284 | $0.70 | $24,999,999 | 49,313,559 | Mar 5, 2025 |
| Ali Faraz | Chief Executive Officer | Award / Grant | 34,424 | — | — | 330,255 | Feb 6, 2025 |
| Tingley Whittemore | Chief Medical Officer | Award / Grant | 31,676 | — | — | 178,782 | Jan 24, 2025 |
| Saito Chihiro | SVP, Accounting and Fin. Ops. | Sale | 2,258 | $2.12 | $4,787 | 60,983 | Nov 18, 2024 |
| Saito Chihiro | SVP, Accounting and Fin. Ops. | Sale | 807 | $2.89 | $2,332 | 63,241 | Aug 16, 2024 |
| Tingley Whittemore | Chief Medical Officer | Sale | 5,803 | $2.89 | $16,771 | 108,731 | Aug 16, 2024 |
| Ali Faraz | Chief Executive Officer | Sale | 3,946 | $2.89 | $11,404 | 188,331 | Aug 16, 2024 |
| Hoey Timothy | Chief Scientific Officer | Sale | 3,300 | $7.00 | $23,100 | 245,346 | Mar 5, 2024 |
| Hoey Timothy | Chief Scientific Officer | Award / Grant | 12,500 | — | — | 248,646 | Feb 23, 2024 |
| Tingley Whittemore | Chief Medical Officer | Award / Grant | 35,000 | — | — | 108,534 | Feb 23, 2024 |
| PATTERSON LEONE D | Chief Fin. and Bus. Officer | Award / Grant | 35,000 | — | — | 95,755 | Feb 23, 2024 |
| Ali Faraz | Chief Executive Officer | Award / Grant | 85,000 | — | — | 198,079 | Feb 23, 2024 |
| Hoey Timothy | Chief Scientific Officer | Sale | 200 | $6.17 | $1,234 | 236,146 | Feb 20, 2024 |
| Hoey Timothy | Chief Scientific Officer | Sale | 4,681 | $5.86 | $27,431 | 242,715 | Feb 16, 2024 |
| Tingley Whittemore | Chief Medical Officer | Sale | 6,500 | $5.86 | $38,090 | 73,534 | Feb 16, 2024 |
| PATTERSON LEONE D | Chief Fin. and Bus. Officer | Sale | 5,201 | $5.86 | $30,478 | 60,755 | Feb 16, 2024 |
| Ali Faraz | Chief Executive Officer | Sale | 6,358 | $5.86 | $37,258 | 113,079 | Feb 16, 2024 |
| COLUMN GROUP III-A, LP | — | Purchase | 2,222,222 | $4.50 | $9,999,999 | 13,599,275 | Feb 12, 2024 |
| GOEDDEL DAVID V | — | Purchase | 2,222,222 | $4.50 | $9,999,999 | 13,599,275 | Feb 12, 2024 |
| Hoey Timothy | Chief Scientific Officer | Sale | 7,243 | $4.26 | $30,855 | 247,396 | Aug 29, 2023 |
| Hoey Timothy | Chief Scientific Officer | Sale | 4,007 | $3.81 | $15,267 | 254,639 | Aug 16, 2023 |
| Tingley Whittemore | Chief Medical Officer | Sale | 5,563 | $3.81 | $21,195 | 76,437 | Aug 16, 2023 |
| PATTERSON LEONE D | Chief Fin. and Bus. Officer | Sale | 4,452 | $3.81 | $16,962 | 64,542 | Aug 16, 2023 |
| Ali Faraz | Chief Executive Officer | Sale | 5,563 | $3.81 | $21,195 | 119,437 | Aug 16, 2023 |
| COLUMN GROUP III, LP | — | Purchase | 6,779 | $2.60 | $17,625 | 11,377,053 | Mar 10, 2023 |
| GOEDDEL DAVID V | — | Purchase | 6,779 | $2.60 | $17,625 | 11,377,053 | Mar 10, 2023 |
| Hoey Timothy | Chief Scientific Officer | Award / Grant | 30,000 | — | — | 258,646 | Feb 15, 2023 |
| Tingley Whittemore | Chief Medical Officer | Award / Grant | 45,000 | — | — | 80,000 | Feb 15, 2023 |
| PATTERSON LEONE D | Chief Fin. and Bus. Officer | Award / Grant | 35,000 | — | — | 67,000 | Feb 15, 2023 |
| Ali Faraz | Chief Executive Officer | Award / Grant | 125,000 | — | — | 125,000 | Feb 15, 2023 |
| COLUMN GROUP III-A, LP | — | Purchase | 1,500,000 | $2.60 | $3,900,000 | 11,370,274 | Feb 8, 2023 |
| GOEDDEL DAVID V | — | Purchase | 1,500,000 | $2.60 | $3,900,000 | 11,370,274 | Feb 8, 2023 |
| COLUMN GROUP III GP, LP | — | Purchase | 69,739 | $2.50 | $174,348 | 9,870,274 | Jan 19, 2023 |
| GOEDDEL DAVID V | — | Purchase | 69,739 | $2.50 | $174,348 | 9,870,274 | Jan 19, 2023 |
| COLUMN GROUP III GP, LP | — | Purchase | 49,463 | $2.49 | $123,163 | 9,664,847 | Jan 18, 2023 |
| GOEDDEL DAVID V | — | Purchase | 135,688 | $2.52 | $341,934 | 9,800,535 | Jan 17, 2023 |
| GOEDDEL DAVID V | — | Purchase | 9,615,384 | $2.60 | $24,999,998 | 9,615,384 | Nov 21, 2022 |